
GLP-2T
Dual Incretin Receptor Agonist Peptide
Specification: 10mg (≥ 99% Purity) (Sterile Lyophilized Vial). Sterile sealed with rubber butyl septum and aluminum crimp.
Product Overview & Summary▾
Dual incretin receptor agonist peptide targeting complementary pathways for insulinotropic response, appetite balance, and visceral homeostasis.
GLP-2T is synthesized to deliver high-affinity dual agonism. Its molecular architecture promotes metabolic flexibility, sustained satiety cues, and lean composition optimization.
Key Pathways & Mechanisms▾
- Dual incretin pathway activation (GLP-1 + GIP)
- Supports insulin sensitivity and glucose disposal
- Calibrated appetite signaling and gastrointestinal motility pacing
- High stoichiometric purity verified by LC-MS
Chemical Identity & Specs▾
Explore Synergistic Peptides
Commonly paired in dual-pathway recovery and longevity research protocols.

Body Protection Compound-157 Synthetic Pentadecapeptide

Thymosin Beta-4 Bio-Active Actin Sequestering Fragment

Modified GRF (1-29) Growth Hormone Secretagogue

Copper Tripeptide-1 Regenerative Complex